 Syros Pharmaceuticals, Inc. NASDAQ:SYRS Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Karen Hunady - Director-Corporate Communications Investor Relations Nancy Simonian - President Chief Executive Officer David Roth - Chief Medical Officer Jason Haas - Chief Financial Officer Conference Call Participants Edward Tenthoff - Piper Sandler Philip Nadeau - Cowen Operator Good day, and welcome to the Q3 2022 Syros Pharmaceuticals, Inc. Earnings Conference Call. At this time, all participants are in listen-only mode. 